Although the clinical relevance remains to be directly tested, preliminary findings indicate that AMPK activity was reduced in the upper small intestine of people with obesity-associated type 2 diabetes as well9. This evidence concerns the gene PRKAA1 and obesity due to melanocortin 4 receptor deficiency.